Entering text into the input field will update the search result below

Akari Therapeutics reports Q4 results

  • Akari Therapeutics (NASDAQ:AKTX): Q4 GAAP EPS of $0.00.
  • Cash of $5.7M
  • Press Release

Recommended For You

More Trending News

About AKTX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AKTX--
Akari Therapeutics, Plc